Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Tragic toll at Hajj pilgrimage: 68 Indian nationals among 645 total deaths During this year’s Hajj pilgrimage, a deeply significant religious event for Muslims around the globe, at least 68… byPallavi MadhirajuJune 19, 2024